1.Young-Hyman D., de Groot M., Hill-Briggs F., Gonzalez JS., Hood K., Peyrot M. Psychosocial care for people with diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2016. 39:2126–40. Erratum in: Diabetes Care. 2017. 40:287Erratum in: Diabetes Care 2017;40):726.
Article
2.USV Pharmaceutical Corporation. Diabetes: a medical od-yssey. Tuckaho: USV Pharmaceutical Corporation;1971.
3.Korean Diabetes Association. Diabetes. 5th ed.Seoul: Panmuneducation;2018.
4.Jeon EJ. Diabetes and depression. Yeungnam Univ J Med. 2018. 35:27–35.
Article
5.Dejgaard A., Gade A., Larsson H., Balle V., Parving A., Parving HH. Evidence for diabetic encephalopathy. Diabet Med. 1991. 8:162–7.
Article
6.Jesulola E., Micalos P., Baguley IJ. Understanding the pathophysiology of depression: from monoamines to the neurogenesis hypothesis model - are we there yet? Behav Brain Res. 2018. 341:79–90.
Article
7.Anderson RJ., Freedland KE., Clouse RE., Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001. 24:1069–78.
8.Gendelman N., Snell-Bergeon JK., McFann K., Kinney G., Paul Wadwa R., Bishop F, et al. Prevalence and correlates of depression in individuals with and without type 1 diabetes. Diabetes Care. 2009. 32:575–9.
Article
9.Winkley K., Ismail K., Landau S., Eisler I. Psychological in-terventions to improve glycaemic control in patients with type 1 diabetes: systematic review and meta-analysis of randomised controlled trials. BMJ. 2006. 333:65.
Article
10.Tabák AG., Akbaraly TN., Batty GD., Kivimäki M. Depression and type 2 diabetes: a causal association? Lancet Diabetes Endocrinol. 2014. 2:236–45.
Article
11.Knol MJ., Twisk JW., Beekman AT., Heine RJ., Snoek FJ., Pouwer F. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia. 2006. 49:837–45.
12.American Diabetes Association Professional Practice Committee; American Diabetes Association Professional Practice Committee., Draznin B., Aroda VR., Bakris G., Ben-son G, et al. 5. Facilitating behavior change and well-being to improve health outcomes: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022. 45(Suppl 1):S60–82.
13.Korean Neuropsychiatric Association. Textbook of neuro-psychiatry. 3rd ed.Seoul: iMiS company;2017.
14.American Psychiatric Association. DSM-5. Diagnostic and statistical manual of mental disorders. 5th ed.Kwon JS, Kim JJ, Namgung G, Park WM, Shin MS, Yoo BH, editors. Seoul: Hakjisa;2015. c2013.
15.Lustman PJ., Anderson RJ., Freedland KE., de Groot M., Carney RM., Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000. 23:934–42.
Article
16.Park HS., Hong YS., Lee HJ., Ha EH., Sung YA. The association between depressive symptoms and glycemic control in the patients with diabetes mellitus. Korean J Med. 2003. 64:204–11.
17.Lin EH., Rutter CM., Katon W., Heckbert SR., Ciechanows-ki P., Oliver MM, et al. Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care. 2010. 33:264–9.
18.Zhang X., Norris SL., Gregg EW., Cheng YJ., Beckles G., Kahn HS. Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol. 2005. 161:652–60.
Article
19.Myers BA., Klingensmith R., de Groot M. Emotional correlates of the COVID-19 pandemic in individuals with and without diabetes. Diabetes Care. 2022. 45:42–58.
Article